S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Germany
TG
Genmab AS (GE9)
Genmab AS (GE9) Financials

Genmab AS (GE9)

195.75

-0.45

(-0.23%)

Closed November 26 3:00PM

Realtime Data

Genmab AS Financial Summary

The current GE9 market cap is 12.86B. The company's latest EPS is DKK 66.2490 and P/E is 3.06.

Income Statement

Year End December 30 2023	2019	2020	2021	2022	2023
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Total Revenue	5.37B	10.11B	8.48B	14.6B	16.47B
Operating Income	2.64B	6.31B	3.02B	6.36B	5.32B
Net Income	2.17B	4.76B	3.01B	5.52B	4.35B

Balance Sheet

Year End December 30 2023	2019	2020	2021	2022	2023
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Total Assets	15.14B	21.14B	24.63B	30.28B	35.29B
Total Liabilities	1.1B	2.02B	2.43B	2.84B	3.68B
Total Equity	14.05B	19.12B	22.2B	27.44B	31.61B

Cash Flow

Year End December 30 2023	2019	2020	2021	2022	2023
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Operating	1.33B	6.43B	2.23B	3.91B	7.38B
Investing	-1.98B	-2.35B	-961M	-2.76B	-1.28B
Financing	3.66B	71M	-420M	-789M	-606M

Stats and Ratios

Market Cap	12.86B
Price to Earnings Ratio	3.06
Price to Sales Ratio	0.81
Price to Cash Ratio	0.9
Price to Book Ratio	0.42
Dividend Yield	-

Share Statistics

Shares Outstanding	65.69M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-
Spread (Intraday)	1.95 (0.99%)

Company Info

Company Name	Genmab AS
Address	kalvebod brygge 43 copenhagen 1260
Website	https://www.genmab.com
Industry	biogenetic (human) (H4)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions